Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 169

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

AI-driven quantification, staging and outcome prediction of COVID-19 pneumonia

Open access
Chassagnon, Guillaume, Vakalopoulou, Maria, Battistella, Enzo, Christodoulidis, Stergios, Hoang-Thi, Trieu-Nghi, Dangeard, Severine, Deutsch, Eric, Andre, Fabrice, Guillo, Enora, Halm, Nara, El Hajj, Stefany, Bompard, Florian, Neveu, Sophie, Hani, Chahinez, Saab, Ines, Campredon, Aliénor, Koulakian, Hasmik, Bennani, Souhail, Freche, Gael, Barat, Maxime, Lombard, Aurelien, Fournier, Laure, Monnier, Hippolyte, Grand, Téodor, Gregory, Jules, Nguyen, Yann, Khalil, Antoine, Mahdjoub, Elyas, Brillet, Pierre-Yves, Tran Ba, Stéphane, Bousson, Valérie, Mekki, Ahmed, Carlier, Robert-Yves, Revel, Marie-Pierre, Paragios, Nikos·2021·Medical Image Analysis

Published version of a preprint

Abstract

Coronavirus disease 2019 (COVID-19) emerged in 2019 and disseminated around the world rapidly. Computed tomography (CT) imaging has been proven to be an important tool for screening, disease quantification and staging. The latter is of extreme importance for organizational anticipation (availability of intensive care unit beds, patient management planning) as well as to accelerate drug development through rapid, reproducible and quantified assessment of treatment response. Even if currently there are no specific guidelines for the staging of the patients, CT together with some clinical and biological biomarkers are used. In this study, we collected a multi-center cohort and we investigated the use of medical imaging and artificial intelligence for disease quantification, staging and outcome prediction. Our approach relies on automatic deep learning-based disease quantification using an ensemble of architectures, and a data-driven consensus for the staging and outcome prediction of the patients fusing imaging biomarkers with clinical and biological attributes. Highly promising results on multiple external/independent evaluation cohorts as well as comparisons with expert human readers demonstrate the potentials of our approach.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.media.2020.101860

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Research works printed but not linked: 30

  1. Anthimopoulos, 2016, Lung pattern classification for interstitial lung diseases using a deep convolutional neural network, IEEE Trans. Med. Imaging, 35, 1207, 10.1109/TMI.2016.2535865 · DOI · Paper page
  2. Anthimopoulos, 2018, Semantic segmentation of pathological lung tissue with dilated fully convolutional networks, IEEE J. Biomed. Health Inform., 23, 714, 10.1109/JBHI.2018.2818620 · DOI
  3. Bai, X., Fang, C., Zhou, Y., Bai, S., Liu, Z., Xia, L., Chen, Q., Xu, Y., Xia, T., Gong, S., et al., 2020. Predicting COVID-19 malignant progression with ai techniques. · DOI
  4. Bermejo-Peláez, 2020, Classification of interstitial lung abnormality patterns with an ensemble of deep convolutional neural networks, Sci. Rep., 10, 1, 10.1038/s41598-019-56989-5 · DOI
  5. Bocchino, 2019, Performance of a new quantitative computed tomography index for interstitial lung disease assessment in systemic sclerosis, Sci. Rep., 9, 1, 10.1038/s41598-019-45990-7 · DOI
  6. Chaganti, S., Balachandran, A., Chabin, G., Cohen, S., Flohr, T., Georgescu, B., Grenier, P., Grbic, S., Liu, S., Mellot, F., et al., 2020. Quantification of tomographic patterns associated with COVID-19 from chest CT. arXiv preprint arXiv:2004.01279 · DOI
  7. Chassagnon, 2020, Deep learning: definition and perspectives for thoracic imaging, Eur. Radiol., 30, 2021, 10.1007/s00330-019-06564-3 · DOI
  8. Christe, 2019, Computer-aided diagnosis of pulmonary fibrosis using deep learning and CT images, Investig. Radiol., 54, 627, 10.1097/RLI.0000000000000574 · DOI
  9. Cottin, 2019, Interstitial lung disease associated with systemic sclerosis (SSC-ILD), Respir. Res., 20, 13, 10.1186/s12931-019-0980-7 · DOI · Paper page
  10. Depeursinge, 2015, Automated classification of usual interstitial pneumonia using regional volumetric texture analysis in high-resolution CT, Investig. Radiol., 50, 261, 10.1097/RLI.0000000000000127 · DOI
  11. Gao, 2018, Holistic classification of CT attenuation patterns for interstitial lung diseases via deep convolutional neural networks, Comput. Methods Biomech. Biomed. Eng., 6, 1
  12. He, K., Zhao, W., Xie, X., Ji, W., Liu, M., Tang, Z., Shi, F., Gao, Y., Liu, J., Zhang, J., et al., 2020. Synergistic learning of lung lobe segmentation and hierarchical multi-instance classification for automated severity assessment of COVID-19 in CT images. arXiv preprint arXiv:2005.03832 · DOI
  13. Guo, 2020, Diabetes is a risk factor for the progression and prognosis of COVID-19, Diabetes/Metab. Res. Rev., 36, e3319, 10.1002/dmrr.3319 · DOI · Paper page
  14. Huang, 2020, Serial quantitative chest CT assessment of COVID-19: deep-learning approach, Radiology, 2, e200075
  15. Huber, 2012, Texture feature ranking with relevance learning to classify interstitial lung disease patterns, Artif. Intell. Med., 56, 91, 10.1016/j.artmed.2012.07.001 · doi:10.1016/j.artmed.2012.07.001
  16. Kolb, 2014, Staging of idiopathic pulmonary fibrosis: past, present and future, Eur. Respir. Rev., 23, 220, 10.1183/09059180.00002114 · DOI
  17. Lafata, 2019, An exploratory radiomics approach to quantifying pulmonary function in CT images, Sci. Rep., 9, 1, 10.1038/s41598-019-48023-5 · DOI
  18. Lassau, N., Ammari, S., Chouzenoux, E., Gortais, H., Herent, P., Devilder, M., Soliman, S., Meyrignac, O., Talabard, M.-P., Lamarque, J.-P., et al., 2020. Ai-based multi-modal integration of clinical characteristics, lab tests and chest CTs improves COVID-19 outcome prediction of hospitalized patients. medRxiv.
  19. Li, 2020, CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19), Eur. Radiol., 30, 4407, 10.1007/s00330-020-06817-6 · DOI · Paper page
  20. Li, M. D., Arun, N. T., Gidwani, M., Chang, K., Deng, F., Little, B. P., Mendoza, D. P., Lang, M., Lee, S. I., O’Shea, A., et al., 2020c. Automated assessment of COVID-19 pulmonary disease severity on chest radiographs using convolutional siamese neural networks. medRxiv. · DOI
  21. Pedregosa, 2011, Scikit-learn: machine learning in python, J. Mach. Learn. Res., 12, 2825
  22. Tang, 2020, Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia, J. Thromb. Haemost., 18, 844, 10.1111/jth.14768 · DOI · Paper page
  23. Tilborghs, S., Dirks, I., Fidon, L., Willems, S., Eelbode, T., Bertels, J., Ilsen, B., Brys, A., Dubbeldam, A., Buls, N., et al., 2020. Comparative study of deep learning methods for the automatic segmentation of lung, lesion and lesion type in CT scans of COVID-19 patients. arXiv preprint arXiv:2007.15546 · arXiv
  24. Terpos, 2020, Hematological findings and complications of COVID-19, Am. J. Hematol., 95, 834, 10.1002/ajh.25829 · DOI · Paper page
  25. Tomassetti, 2015, Staging systems and disease severity assessment in interstitial lung diseases, Curr. Opin. Pulm. Med., 21, 463, 10.1097/MCP.0000000000000198 · DOI
  26. Van Griethuysen, 2017, Computational radiomics system to decode the radiographic phenotype, Cancer Res., 77, e104, 10.1158/0008-5472.CAN-17-0339 · doi:10.1158/0008-5472.can-17-0339
  27. Wu, 2019, Computed tomographic biomarkers in idiopathic pulmonary fibrosis. the future of quantitative analysis, Am. J. Respir. Critical Care Med., 199, 12, 10.1164/rccm.201803-0444PP · DOI
  28. Yuan, 2020, Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China, PLoS One, 15, e0230548, 10.1371/journal.pone.0230548 · DOI · Paper page
  29. Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 385, 1054, 10.1016/S0140-6736(20)30566-3 · DOI · Paper page
  30. Zhu, 2020, A novel coronavirus from patients with pneumonia in china, 2019, New Engl. J. Med., 382, 727, 10.1056/NEJMoa2001017 · DOI · Paper page

Cited by

See all 169

Metadata

Authors
Chassagnon, G., Vakalopoulou, M., Battistella, E., Christodoulidis, S., Hoang-Thi, T.-N., Dangeard, S., Deutsch, E., Andre, F., Guillo, E., Halm, N., El Hajj, S., Bompard, F., Neveu, S., Hani, C., Saab, I., Campredon, A., Koulakian, H., Bennani, S., Freche, G., Barat, M., Lombard, A., Fournier, L., Monnier, H., Grand, T., Gregory, J., Nguyen, Y., Khalil, A., Mahdjoub, E., Brillet, P.-Y., Tran Ba, S., Bousson, V., Mekki, A., Carlier, R.-Y., Revel, M.-P., & Paragios, N.
Venue
Medical Image Analysis
Publisher
Elsevier BV
Published
2021-01
Volume
67
Pages
101860
ISSN
1361-8415 (ISSN-L)
OpenAlex
W3093455605
Cited by
169
References
18
FWCI
15.46
Type
journal article
Language
en
Open access
hybrid
Funders
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (188153)
  • Fondation pour la Recherche Médicale (DIC20161236437)
  • GE Healthcare
  • Horizon 2020 (880314)
  • Horizon 2020 Framework Programme

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: AI-driven quantification, staging and outcome prediction of COVID-19 pneumonia. https://app.cochat.ai/papers/10.1016/j.media.2020.101860
The paper
Chassagnon, G., Vakalopoulou, M., Battistella, E., Christodoulidis, S., Hoang-Thi, T.-N., Dangeard, S., Deutsch, E., Andre, F., Guillo, E., Halm, N., El Hajj, S., Bompard, F., Neveu, S., Hani, C., Saab, I., Campredon, A., Koulakian, H., Bennani, S., Freche, G., . . . Paragios, N. (2021). AI-driven quantification, staging and outcome prediction of COVID-19 pneumonia. Medical Image Analysis. https://doi.org/10.1016/j.media.2020.101860

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.